vasoactive-intestinal-peptide has been researched along with pirarubicin* in 1 studies
1 other study(ies) available for vasoactive-intestinal-peptide and pirarubicin
Article | Year |
---|---|
Targeting breast cancer using pirarubicin-loaded vasoactive intestinal peptide grafted sterically stabilized micelles.
In this study the chemotherapeutic agent Pirarubicin (PRB) which is known for its serious side effects was actively targeted to the breast cancer cells by uploading it to the biocompatible and biodegradable Sterically Stabilized Micelles (SSMs) made of 1,2- Distearoyl- sn- glycero‑3- phosphoethanolamine- N- methoxy‑ polyethylene glycol 2000 (DSPE-PEG Topics: Animals; Breast Neoplasms; Doxorubicin; Female; Humans; Mice; Mice, Nude; Micelles; Polyethylene Glycols; Vasoactive Intestinal Peptide | 2021 |